# Add-on Diuretics in Acute Decompensated Heart Failure

> **NCT07372040** · PHASE2 · RECRUITING · sponsor: **Tanta University** · enrollment: 66 (estimated)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** empagliflozin
- **DRUG:** Acetazolamide
- **DRUG:** metolazone

## Key facts

- **NCT ID:** NCT07372040
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07372040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07372040, "Add-on Diuretics in Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07372040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*